PDB Short entry for 2BJ4 HEADER NUCLEAR RECEPTOR 28-JAN-05 2BJ4 TITLE ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH A PHAGE-DISPLAY DERIVED TITLE 2 PEPTIDE ANTAGONIST COMPND MOL_ID: 1; COMPND 2 MOLECULE: ESTROGEN RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 305-533 (LIGAND-BINDING DOMAIN); COMPND 5 SYNONYM: ER, ESTRADIOL RECEPTOR, ER-ALPHA; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: ESTROGEN RECEPTOR; COMPND 9 CHAIN: B; COMPND 10 FRAGMENT: RESIDUES 305-533 (LIGAND-BINDING DOMAIN); COMPND 11 SYNONYM: ER, ESTRADIOL RECEPTOR, ER-ALPHA; COMPND 12 ENGINEERED: YES; COMPND 13 MOL_ID: 3; COMPND 14 MOLECULE: PEPTIDE ANTAGONIST; COMPND 15 CHAIN: C, D; COMPND 16 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_VARIANT: C41; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET15B; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 14 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 15 EXPRESSION_SYSTEM_VARIANT: C41; SOURCE 16 EXPRESSION_SYSTEM_PLASMID: PET15B; SOURCE 17 MOL_ID: 3; SOURCE 18 SYNTHETIC: YES; SOURCE 19 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 20 ORGANISM_TAXID: 32630 KEYWDS NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, PEPTIDE ANTAGONIST, LIGAND- KEYWDS 2 BINDING DOMAIN (LBD), DNA-BINDING, NUCLEAR PROTEIN STEROID-BINDING EXPDTA X-RAY DIFFRACTION AUTHOR E.KONG,N.HELDRING,J.A.GUSTAFSSON,E.TREUTER,R.E.HUBBARD,A.C.W.PIKE REVDAT 6 24-JAN-18 2BJ4 1 SOURCE REVDAT 5 13-JUL-11 2BJ4 1 VERSN REVDAT 4 02-FEB-10 2BJ4 1 VERSN REVDAT 3 24-FEB-09 2BJ4 1 VERSN REVDAT 2 16-MAR-05 2BJ4 1 JRNL REVDAT 1 16-FEB-05 2BJ4 0 JRNL AUTH E.KONG,N.HELDRING,J.A.GUSTAFSSON,E.TREUTER,R.E.HUBBARD, JRNL AUTH 2 A.C.W.PIKE JRNL TITL DELINEATION OF A UNIQUE PROTEIN-PROTEIN INTERACTION SITE ON JRNL TITL 2 THE SURFACE OF THE ESTROGEN RECEPTOR JRNL REF PROC.NATL.ACAD.SCI.USA V. 102 3593 2005 JRNL REFN ISSN 0027-8424 JRNL PMID 15728727 JRNL DOI 10.1073/PNAS.0407189102 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0000 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.99 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 94.8 REMARK 3 NUMBER OF REFLECTIONS : 32933 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.189 REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.219 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1725 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1905 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.1960 REMARK 3 BIN FREE R VALUE SET COUNT : 85 REMARK 3 BIN FREE R VALUE : 0.2190 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3649 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 58 REMARK 3 SOLVENT ATOMS : 179 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 26.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.81 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.06000 REMARK 3 B22 (A**2) : 0.08000 REMARK 3 B33 (A**2) : -0.01000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.185 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.156 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.107 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.949 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.935 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3817 ; 0.014 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 3595 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5156 ; 1.378 ; 1.975 REMARK 3 BOND ANGLES OTHERS (DEGREES): 8256 ; 0.838 ; 3.002 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 455 ; 5.366 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 161 ;36.003 ;24.037 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 691 ;15.759 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 20 ;17.796 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 597 ; 0.087 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4108 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 722 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 918 ; 0.217 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 3493 ; 0.170 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): 2194 ; 0.087 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 197 ; 0.146 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 14 ; 0.157 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 62 ; 0.209 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 13 ; 0.194 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2507 ; 0.965 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3699 ; 1.358 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1652 ; 2.162 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1457 ; 3.163 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 305 A 528 REMARK 3 RESIDUE RANGE : C 1 C 11 REMARK 3 ORIGIN FOR THE GROUP (A): 15.6859 48.4862 28.9369 REMARK 3 T TENSOR REMARK 3 T11: -0.1419 T22: -0.1259 REMARK 3 T33: -0.1471 T12: -0.0265 REMARK 3 T13: 0.0260 T23: -0.0223 REMARK 3 L TENSOR REMARK 3 L11: 1.5623 L22: 2.5640 REMARK 3 L33: 2.4887 L12: -0.5386 REMARK 3 L13: 0.6203 L23: -0.8456 REMARK 3 S TENSOR REMARK 3 S11: 0.0140 S12: -0.0358 S13: -0.0557 REMARK 3 S21: -0.0573 S22: -0.0426 S23: -0.0741 REMARK 3 S31: 0.0518 S32: 0.1245 S33: 0.0286 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 304 B 529 REMARK 3 RESIDUE RANGE : D 1 D 11 REMARK 3 ORIGIN FOR THE GROUP (A): 2.5196 44.4142 6.8058 REMARK 3 T TENSOR REMARK 3 T11: -0.1361 T22: -0.1205 REMARK 3 T33: -0.1346 T12: -0.0101 REMARK 3 T13: 0.0019 T23: -0.0019 REMARK 3 L TENSOR REMARK 3 L11: 1.3179 L22: 2.9131 REMARK 3 L33: 2.7056 L12: 0.1634 REMARK 3 L13: 0.1558 L23: 0.3322 REMARK 3 S TENSOR REMARK 3 S11: -0.0330 S12: 0.0779 S13: -0.0543 REMARK 3 S21: -0.0463 S22: -0.0191 S23: 0.1714 REMARK 3 S31: 0.1112 S32: 0.0147 S33: 0.0522 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2BJ4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 28-JAN-05. REMARK 100 THE DEPOSITION ID IS D_1290021502. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 34714 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.0 REMARK 200 DATA REDUNDANCY : 4.400 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 8.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 78.1 REMARK 200 DATA REDUNDANCY IN SHELL : 3.20 REMARK 200 R MERGE FOR SHELL (I) : 0.32000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1ERE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.59 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.41 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG2000MME 0.6M SODIUM FORMATE REMARK 280 0.1M TRIS PH8, PH 8.00 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.38000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 52.82000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 49.38000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 52.82000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.38000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 49.38000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5900 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20370 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -37.6 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 FUNCTION: NUCLEAR HORMONE RECEPTOR REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 282 REMARK 465 GLY A 283 REMARK 465 SER A 284 REMARK 465 SER A 285 REMARK 465 HIS A 286 REMARK 465 HIS A 287 REMARK 465 HIS A 288 REMARK 465 HIS A 289 REMARK 465 HIS A 290 REMARK 465 HIS A 291 REMARK 465 SER A 292 REMARK 465 SER A 293 REMARK 465 GLY A 294 REMARK 465 LEU A 295 REMARK 465 VAL A 296 REMARK 465 PRO A 297 REMARK 465 ARG A 298 REMARK 465 GLY A 299 REMARK 465 SER A 300 REMARK 465 HIS A 301 REMARK 465 MET A 302 REMARK 465 GLU A 303 REMARK 465 ASN A 304 REMARK 465 TYR A 331 REMARK 465 ASP A 332 REMARK 465 PRO A 333 REMARK 465 THR A 334 REMARK 465 ARG A 335 REMARK 465 SER A 463 REMARK 465 LYS A 529 REMARK 465 CYS A 530 REMARK 465 LYS A 531 REMARK 465 ASN A 532 REMARK 465 VAL A 533 REMARK 465 MET B 282 REMARK 465 GLY B 283 REMARK 465 SER B 284 REMARK 465 SER B 285 REMARK 465 HIS B 286 REMARK 465 HIS B 287 REMARK 465 HIS B 288 REMARK 465 HIS B 289 REMARK 465 HIS B 290 REMARK 465 HIS B 291 REMARK 465 SER B 292 REMARK 465 SER B 293 REMARK 465 GLY B 294 REMARK 465 LEU B 295 REMARK 465 VAL B 296 REMARK 465 PRO B 297 REMARK 465 ARG B 298 REMARK 465 GLY B 299 REMARK 465 SER B 300 REMARK 465 HIS B 301 REMARK 465 MET B 302 REMARK 465 GLU B 303 REMARK 465 PHE B 461 REMARK 465 LEU B 462 REMARK 465 SER B 463 REMARK 465 SER B 464 REMARK 465 CYS B 530 REMARK 465 LYS B 531 REMARK 465 ASN B 532 REMARK 465 VAL B 533 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 416 CB CG CD CE NZ REMARK 470 GLU A 419 CG CD OE1 OE2 REMARK 470 LEU A 462 CG CD1 CD2 REMARK 470 SER A 464 CB OG REMARK 470 LYS A 492 CD CE NZ REMARK 470 ASN B 304 CG OD1 ND2 REMARK 470 ARG B 335 NE CZ NH1 NH2 REMARK 470 GLU B 339 CG CD OE1 OE2 REMARK 470 GLU B 419 CD OE1 OE2 REMARK 470 THR B 465 OG1 CG2 REMARK 470 LEU B 466 CG CD1 CD2 REMARK 470 LYS B 467 CG CD CE NZ REMARK 470 LYS B 472 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 THR B 334 CB THR B 334 OG1 0.145 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 515 NE - CZ - NH1 ANGL. DEV. = 3.5 DEGREES REMARK 500 ARG A 515 NE - CZ - NH2 ANGL. DEV. = -3.3 DEGREES REMARK 500 ARG B 515 NE - CZ - NH2 ANGL. DEV. = -3.3 DEGREES REMARK 500 ASP D 5 CB - CG - OD2 ANGL. DEV. = 6.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 461 -86.95 -50.04 REMARK 500 LEU B 408 79.87 -153.76 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE OHT A 1529 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE OHT B 1530 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1A52 RELATED DB: PDB REMARK 900 ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN COMPLEXED TO ESTRADIOL REMARK 900 RELATED ID: 1AKF RELATED DB: PDB REMARK 900 HOMOLOGOUS-EXTENSION-BASED MODEL OF HUMAN ESTROGEN RECEPTOR WITH REMARK 900 BOUND ESTRADIOL, THEORETICAL MODEL REMARK 900 RELATED ID: 1ERE RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR LIGAND-BINDING DOMAIN IN COMPLEX WITH REMARK 900 17BETA-ESTRADIOL REMARK 900 RELATED ID: 1ERR RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR LIGAND-BINDING DOMAIN IN COMPLEX WITH REMARK 900 RALOXIFENE REMARK 900 RELATED ID: 1G50 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A WILD TYPE HER ALPHA LBD AT 2.9ANGSTROM REMARK 900 RESOLUTION REMARK 900 RELATED ID: 1GWQ RELATED DB: PDB REMARK 900 HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX REMARK 900 WITH RALOXIFENE CORE AND TIF2 NRBOX2 PEPTIDE REMARK 900 RELATED ID: 1GWR RELATED DB: PDB REMARK 900 HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX REMARK 900 WITH 17BETA-OESTRADIOL AND TIF2 NRBOX3 PEPTIDE REMARK 900 RELATED ID: 1HCP RELATED DB: PDB REMARK 900 MOL_ID: 1; MOLECULE: HUMAN/CHICKEN ESTROGEN RECEPTOR; CHAIN: NULL; REMARK 900 DOMAIN: DEOXYRIBONUCLEIC ACID-BINDING DOMAIN (ERDBD); ENGINEERED: REMARK 900 YES REMARK 900 RELATED ID: 1HCQ RELATED DB: PDB REMARK 900 MOL_ID: 1; MOLECULE: HUMAN/CHICKEN ESTROGEN RECEPTOR; CHAIN: A, B, REMARK 900 E, F; DOMAIN: DEOXYRIBONUCLEIC ACID-BINDING DOMAIN (ERDBD); REMARK 900 ENGINEERED: YES; MOL_ID: 2; MOLECULE: DEOXYRIBONUCLEIC ACID (5'-D( REMARK 900 CPCPAPGPGPTPCPAPCPAPGPTPGP APCPCPTPG)-3') (DOT) DEOXYRIBONUCLEIC REMARK 900 ACID (5'- D(CPCPAPGPGPTPCPA PCPTPGPTPGPAPCPCPTPG)-3'); CHAIN: C, D, REMARK 900 G, H REMARK 900 RELATED ID: 1L2I RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN INCOMPLEX WITH REMARK 900 (R,R)-5,11-CIS- DIETHYL-5,6,11,12- TETRAHYDROCHRYSENE-2,8- DIOL AND REMARK 900 A GLUCOCORTICOID RECEPTORINTERACTING PROTEIN 1 NR BOX II PEPTIDE REMARK 900 RELATED ID: 1PCG RELATED DB: PDB REMARK 900 HELIX-STABILIZED CYCLIC PEPTIDES AS SELECTIVE INHIBITORS OFSTEROID REMARK 900 RECEPTOR-COACTIVATOR INTERACTIONS REMARK 900 RELATED ID: 1QKT RELATED DB: PDB REMARK 900 RELATED ID: 1QKU RELATED DB: PDB REMARK 900 RELATED ID: 1R5K RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN INCOMPLEX WITH REMARK 900 GW5638 REMARK 900 RELATED ID: 1SJ0 RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN INCOMPLEX WITH REMARK 900 THE ANTAGONIST LIGAND 4-D REMARK 900 RELATED ID: 1UOM RELATED DB: PDB REMARK 900 THE STRUCTURE OF ESTROGEN RECEPTOR IN COMPLEX WITH A SELECTIVE AND REMARK 900 POTENT TETRAHYDROISOCHIOLIN LIGAND. REMARK 900 RELATED ID: 1XP1 RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN INCOMPLEX WITH REMARK 900 COMPOUND 15 REMARK 900 RELATED ID: 1XP6 RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN INCOMPLEX WITH REMARK 900 COMPOUND 16 REMARK 900 RELATED ID: 1XP9 RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN INCOMPLEX WITH REMARK 900 COMPOUND 18 REMARK 900 RELATED ID: 1XPC RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN INCOMPLEX WITH REMARK 900 COMPOUND 19 REMARK 900 RELATED ID: 3ERD RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN INCOMPLEX WITH REMARK 900 DIETHYLSTILBESTROL AND A GLUCOCORTICOIDRECEPTOR INTERACTING PROTEIN REMARK 900 1 NR BOX II PEPTIDE REMARK 900 RELATED ID: 3ERT RELATED DB: PDB REMARK 900 HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH REMARK 900 4-HYDROXYTAMOXIFEN REMARK 999 REMARK 999 SEQUENCE REMARK 999 N-TERMINAL HIS-TAG LBD TRUNCATED AT END OF H11 DBREF 2BJ4 A 282 304 PDB 2BJ4 2BJ4 282 304 DBREF 2BJ4 A 305 533 UNP P03372 ESR1_HUMAN 305 533 DBREF 2BJ4 B 282 304 PDB 2BJ4 2BJ4 282 304 DBREF 2BJ4 B 305 533 UNP P03372 ESR1_HUMAN 305 533 DBREF 2BJ4 C 1 11 PDB 2BJ4 2BJ4 1 11 DBREF 2BJ4 D 1 11 PDB 2BJ4 2BJ4 1 11 SEQRES 1 A 252 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 252 LEU VAL PRO ARG GLY SER HIS MET GLU ASN SER LEU ALA SEQRES 3 A 252 LEU SER LEU THR ALA ASP GLN MET VAL SER ALA LEU LEU SEQRES 4 A 252 ASP ALA GLU PRO PRO ILE LEU TYR SER GLU TYR ASP PRO SEQRES 5 A 252 THR ARG PRO PHE SER GLU ALA SER MET MET GLY LEU LEU SEQRES 6 A 252 THR ASN LEU ALA ASP ARG GLU LEU VAL HIS MET ILE ASN SEQRES 7 A 252 TRP ALA LYS ARG VAL PRO GLY PHE VAL ASP LEU THR LEU SEQRES 8 A 252 HIS ASP GLN VAL HIS LEU LEU GLU CYS ALA TRP LEU GLU SEQRES 9 A 252 ILE LEU MET ILE GLY LEU VAL TRP ARG SER MET GLU HIS SEQRES 10 A 252 PRO GLY LYS LEU LEU PHE ALA PRO ASN LEU LEU LEU ASP SEQRES 11 A 252 ARG ASN GLN GLY LYS CYS VAL GLU GLY MET VAL GLU ILE SEQRES 12 A 252 PHE ASP MET LEU LEU ALA THR SER SER ARG PHE ARG MET SEQRES 13 A 252 MET ASN LEU GLN GLY GLU GLU PHE VAL CYS LEU LYS SER SEQRES 14 A 252 ILE ILE LEU LEU ASN SER GLY VAL TYR THR PHE LEU SER SEQRES 15 A 252 SER THR LEU LYS SER LEU GLU GLU LYS ASP HIS ILE HIS SEQRES 16 A 252 ARG VAL LEU ASP LYS ILE THR ASP THR LEU ILE HIS LEU SEQRES 17 A 252 MET ALA LYS ALA GLY LEU THR LEU GLN GLN GLN HIS GLN SEQRES 18 A 252 ARG LEU ALA GLN LEU LEU LEU ILE LEU SER HIS ILE ARG SEQRES 19 A 252 HIS MET SER ASN LYS GLY MET GLU HIS LEU TYR SER MET SEQRES 20 A 252 LYS CYS LYS ASN VAL SEQRES 1 B 252 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 252 LEU VAL PRO ARG GLY SER HIS MET GLU ASN SER LEU ALA SEQRES 3 B 252 LEU SER LEU THR ALA ASP GLN MET VAL SER ALA LEU LEU SEQRES 4 B 252 ASP ALA GLU PRO PRO ILE LEU TYR SER GLU TYR ASP PRO SEQRES 5 B 252 THR ARG PRO PHE SER GLU ALA SER MET MET GLY LEU LEU SEQRES 6 B 252 THR ASN LEU ALA ASP ARG GLU LEU VAL HIS MET ILE ASN SEQRES 7 B 252 TRP ALA LYS ARG VAL PRO GLY PHE VAL ASP LEU THR LEU SEQRES 8 B 252 HIS ASP GLN VAL HIS LEU LEU GLU CYS ALA TRP LEU GLU SEQRES 9 B 252 ILE LEU MET ILE GLY LEU VAL TRP ARG SER MET GLU HIS SEQRES 10 B 252 PRO GLY LYS LEU LEU PHE ALA PRO ASN LEU LEU LEU ASP SEQRES 11 B 252 ARG ASN GLN GLY LYS CCS VAL GLU GLY MET VAL GLU ILE SEQRES 12 B 252 PHE ASP MET LEU LEU ALA THR SER SER ARG PHE ARG MET SEQRES 13 B 252 MET ASN LEU GLN GLY GLU GLU PHE VAL CYS LEU LYS SER SEQRES 14 B 252 ILE ILE LEU LEU ASN SER GLY VAL TYR THR PHE LEU SER SEQRES 15 B 252 SER THR LEU LYS SER LEU GLU GLU LYS ASP HIS ILE HIS SEQRES 16 B 252 ARG VAL LEU ASP LYS ILE THR ASP THR LEU ILE HIS LEU SEQRES 17 B 252 MET ALA LYS ALA GLY LEU THR LEU GLN GLN GLN HIS GLN SEQRES 18 B 252 ARG LEU ALA GLN LEU LEU LEU ILE LEU SER HIS ILE ARG SEQRES 19 B 252 HIS MET SER ASN LYS GLY MET GLU HIS LEU TYR SER MET SEQRES 20 B 252 LYS CYS LYS ASN VAL SEQRES 1 C 11 LEU THR SER ARG ASP PHE GLY SER TRP TYR ALA SEQRES 1 D 11 LEU THR SER ARG ASP PHE GLY SER TRP TYR ALA MODRES 2BJ4 CCS B 417 CYS CARBOXYMETHYLATED CYSTEINE HET CCS B 417 10 HET OHT A1529 29 HET OHT B1530 29 HETNAM CCS CARBOXYMETHYLATED CYSTEINE HETNAM OHT 4-HYDROXYTAMOXIFEN FORMUL 2 CCS C5 H9 N O4 S FORMUL 5 OHT 2(C26 H29 N O2) FORMUL 7 HOH *179(H2 O) HELIX 1 1 SER A 305 LEU A 310 5 6 HELIX 2 2 THR A 311 ALA A 322 1 12 HELIX 3 3 SER A 338 ARG A 363 1 26 HELIX 4 4 GLY A 366 LEU A 370 5 5 HELIX 5 5 THR A 371 MET A 396 1 26 HELIX 6 6 ARG A 412 LYS A 416 1 5 HELIX 7 7 GLY A 420 ASN A 439 1 20 HELIX 8 8 GLN A 441 SER A 456 1 16 HELIX 9 9 GLY A 457 PHE A 461 5 5 HELIX 10 10 THR A 465 ALA A 493 1 29 HELIX 11 11 THR A 496 MET A 528 1 33 HELIX 12 12 LEU B 306 LEU B 310 5 5 HELIX 13 13 THR B 311 ALA B 322 1 12 HELIX 14 14 ARG B 335 GLU B 339 5 5 HELIX 15 15 SER B 341 LYS B 362 1 22 HELIX 16 16 GLY B 366 LEU B 370 5 5 HELIX 17 17 THR B 371 MET B 396 1 26 HELIX 18 18 ASN B 413 VAL B 418 5 6 HELIX 19 19 GLY B 420 MET B 438 1 19 HELIX 20 20 GLN B 441 SER B 456 1 16 HELIX 21 21 THR B 465 ALA B 493 1 29 HELIX 22 22 THR B 496 MET B 528 1 33 HELIX 23 23 THR C 2 PHE C 6 5 5 HELIX 24 24 SER D 3 PHE D 6 5 4 SHEET 1 AA 2 LYS A 401 ALA A 405 0 SHEET 2 AA 2 LEU A 408 ASP A 411 -1 O LEU A 408 N PHE A 404 SHEET 1 BA 2 LYS B 401 ALA B 405 0 SHEET 2 BA 2 LEU B 408 ASP B 411 -1 O LEU B 408 N ALA B 405 LINK C LYS B 416 N CCS B 417 1555 1555 1.32 LINK C CCS B 417 N VAL B 418 1555 1555 1.32 SITE 1 AC1 11 LEU A 346 THR A 347 ALA A 350 ASP A 351 SITE 2 AC1 11 GLU A 353 LEU A 354 ARG A 394 PHE A 404 SITE 3 AC1 11 MET A 421 LEU A 428 GLY A 521 SITE 1 AC2 16 TYR B 331 PRO B 333 MET B 343 LEU B 346 SITE 2 AC2 16 THR B 347 ALA B 350 ASP B 351 GLU B 353 SITE 3 AC2 16 LEU B 354 TRP B 383 ARG B 394 PHE B 404 SITE 4 AC2 16 MET B 421 ILE B 424 GLY B 521 HIS B 524 CRYST1 50.760 98.760 105.640 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019701 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010126 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009466 0.00000 MTRIX1 1 -0.976510 -0.201800 0.075520 26.17764 1 MTRIX2 1 -0.212370 0.960610 -0.179260 6.96425 1 MTRIX3 1 -0.036370 -0.191090 -0.980900 45.18856 1 MTRIX1 2 -0.975130 -0.208060 0.076330 26.42859 1 MTRIX2 2 -0.219010 0.957370 -0.188370 7.67486 1 MTRIX3 2 -0.033880 -0.200400 -0.979130 45.78958 1